July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Understanding barriers to glaucoma treatment adherence among patients in South India
Author Affiliations & Notes
  • OLIVIA KILLEEN
    Ophthalmology, University of Michigan Kellogg Eye Center, Ann Arbor, Michigan, United States
  • Manju Pillai
    Aravind Eye Hospital, Madurai, Tamil Nadu, India
  • B. Udayakumar
    Aravind Eye Hospital, Madurai, Tamil Nadu, India
  • Sujani Shroff
    Aravind Eye Hospital, Madurai, Tamil Nadu, India
  • Menaka Vimalanathan
    Aravind Eye Hospital, Madurai, Tamil Nadu, India
  • Juno Cho
    Ophthalmology, University of Michigan Kellogg Eye Center, Ann Arbor, Michigan, United States
  • Paula Anne Newman-Casey
    Ophthalmology, University of Michigan Kellogg Eye Center, Ann Arbor, Michigan, United States
  • Footnotes
    Commercial Relationships   OLIVIA KILLEEN, None; Manju Pillai, None; B. Udayakumar, None; Sujani Shroff, None; Menaka Vimalanathan, None; Juno Cho, None; Paula Anne Newman-Casey, None
  • Footnotes
    Support  Research to Prevent Blindness Career Development Award
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 1023. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      OLIVIA KILLEEN, Manju Pillai, B. Udayakumar, Sujani Shroff, Menaka Vimalanathan, Juno Cho, Paula Anne Newman-Casey; Understanding barriers to glaucoma treatment adherence among patients in South India. Invest. Ophthalmol. Vis. Sci. 2019;60(9):1023.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Data on barriers to glaucoma treatment adherence in South India is limited; improved knowledge of these barriers is needed to advance disease self-management programs. Patient counseling based on Self-Determination Theory (SDT) has been shown to improve treatment adherence. We aimed to use the theoretical framework of SDT to understand barriers to glaucoma treatment adherence in South India to inform future interventions.

Methods : Glaucoma patients ≥ 18 years old taking ≥1 glaucoma medication were approached in the waiting rooms at the Aravind Eye Hospital (Madurai, India). Patients were screened with a validated medication adherence tool and those who were non-adherent or >3 months late for follow-up were invited to participate in semi-structured interviews on barriers to glaucoma treatment. Interviews were audio-recorded, transcribed, and translated into English. Two researchers identified themes and coded the transcripts.

Results : 70/167 (42%) did not adhere to drops. The 45 interviewed were 62 ±12 years old and took 1.6 ± 0.7 drops. 42 (93%) were not adherent to glaucoma mediation and 21 (47%) were late for follow-up. Key barriers to medication adherence were difficulty obtaining drops (20, 44%), being busy (18, 40%), and expense (17, 38%). Key barriers to follow-up were distance to hospital (21, 47%), expense (20, 44%), and lack of escort (15, 33%). These barriers can be grouped into the three basic psychological needs of SDT modified for an Indian context: relatedness, competence, and autonomy of the family.

Conclusions : Previously, only 6% of glaucoma patients surveyed in South India self-reported medication non-adherence; our finding of 42% non-adherence is more in line with glaucoma medication adherence rates around the world. Previous studies identified barriers to glaucoma treatment adherence in South India using surveys and questionnaires; to our knowledge, this is the first study to use semi-structured interviews to elicit rich qualitative data on treatment barriers in this population. We found that complex factors cause high rates of glaucoma treatment non-adherence in South India. In the past, counseling that provided intellectual information about glaucoma did not improve treatment adherence at Aravind. An approach based on SDT modified for an Indian context, in which counseling aims to support patients’ and their families’ motivation for behavior change, may be more impactful.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×